Prevalence of extended-spectrum beta-lactamase producing bacteria from animal origin: A systematic review and meta-analysis report from India
SP Kuralayanapalya, SS Patil, S Hamsapriya… - PLoS …, 2019 - journals.plos.org
Antimicrobial resistance (AMR) due to the emergence and spread of extended-spectrum
beta-lactamase (ESBL) producing bacteria are becoming a serious global public health …
beta-lactamase (ESBL) producing bacteria are becoming a serious global public health …
Comprehensive study of antimicrobial susceptibility pattern and extended spectrum beta-lactamase (ESBL) prevalence in bacteria isolated from urine samples
MJ Gharavi, J Zarei, P Roshani-Asl, Z Yazdanyar… - Scientific reports, 2021 - nature.com
Nowadays, increasing extended-spectrum β-lactamase (ESBL)-producing bacteria have
become a global concern because of inducing resistance toward most of the antimicrobial …
become a global concern because of inducing resistance toward most of the antimicrobial …
Enzyme inhibitors: the best strategy to tackle superbug NDM-1 and its variants
X Li, D Zhao, W Li, J Sun, X Zhang - International Journal of Molecular …, 2021 - mdpi.com
Multidrug bacterial resistance endangers clinically effective antimicrobial therapy and
continues to cause major public health problems, which have been upgraded to …
continues to cause major public health problems, which have been upgraded to …
Extended-spectrum Beta-lactamase and AmpC beta-lactamases producing gram negative bacilli isolated from clinical specimens at International Clinical Laboratories …
Background Extended spectrum Beta-lactamases (ESBLs) and AmpC beta-lactamases
(AmpC) are the common enzymes produced by gram negative bacilli, which are their main …
(AmpC) are the common enzymes produced by gram negative bacilli, which are their main …
[HTML][HTML] Phenotypic and genotypic distribution of ESBL, AmpC β-lactamase and carbapenemase-producing Enterobacteriaceae in community-acquired and hospital …
PDVM Perera, S Gamage, HSM De Silva… - Journal of global …, 2022 - Elsevier
ABSTRACT Objectives Although Sri Lanka belongs to a region with a high prevalence of
extended-spectrum β-lactamase (ESBL), AmpC β-lactamase and carbapenemase …
extended-spectrum β-lactamase (ESBL), AmpC β-lactamase and carbapenemase …
Identification of metallo-β-lactamases and AmpC production among Escherichia coli strains isolated from hemodialysis patients with urinary tract infection
A Bahramian, S Khoshnood, N Hashemi… - Molecular Biology …, 2021 - Springer
Background This study aimed to identify metallo-β-lactamases (MBLs) and AmpC β-
lactamases-producing Escherichia coli isolates obtained from hemodialysis (HD) patients …
lactamases-producing Escherichia coli isolates obtained from hemodialysis (HD) patients …
Multidrug‐Resistant and Carbapenemase‐Producing Enterobacteriaceae in Addis Ababa, Ethiopia
Background. The emergence and spread of multi‐drug resistant (MDR) bacteria have
become a public health problem in recent years. For the last many years, carbapenem …
become a public health problem in recent years. For the last many years, carbapenem …
[HTML][HTML] Escherichia coli extraintestinal, resistencia antimicrobiana y producción de betalactamasas en aislados cubanos
D Quiñones Pérez, Y Betancourt González… - Revista Cubana de …, 2020 - scielo.sld.cu
Objetivo: Describir el comportamiento clínico de E. coli extraintestinal en hospitales
cubanos, así como determinar la resistencia antimicrobiana y la producción de …
cubanos, así como determinar la resistencia antimicrobiana y la producción de …
[PDF][PDF] Phenotypic and Molecular Study of Extended-Spectrum β-lactamases Producing Enterobacteriaceae from Urinary Tract Infection in Zakho city, Kurdistan …
The prevalence of ESBLs producing Enterobacteriaceae are increasing locally and globally.
This study aimed to investigate the antibiotic susceptibility profile of Enterobacteriaceae …
This study aimed to investigate the antibiotic susceptibility profile of Enterobacteriaceae …
Molecular detection of the New Delhi metallo-β-lactamase clinical variant with double mutation-V88L and M154L in Escherichia coli isolates from South India
SD Mitra, SC Sebastian, I Rekha, P Irshad… - Gene Reports, 2020 - Elsevier
Carbapenem is usually prescribed as a last resort of antibiotic for treating drug resistant
Gram-negative bacterial infections. However, the rise in carbapenem resistance due to the …
Gram-negative bacterial infections. However, the rise in carbapenem resistance due to the …